Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-017-1519-8
Abstract: The effectiveness and safety of apixaban for stroke prevention in atrial fibrillation (SPAF) demonstrated in ARISTOTLE needs to be confirmed in daily care. To evaluate effectiveness and safety of apixaban therapy in SPAF patients in…
read more here.
Keywords:
100 patient;
patient years;
safety apixaban;
daily care ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Advances in Therapy"
DOI: 10.1007/s12325-017-0573-0
Abstract: IntroductionWe characterized the safety and tolerability of empagliflozin in patients with type 2 diabetes (T2DM) randomized 1:1:1 to placebo, empagliflozin 10 mg, or empagliflozin 25 mg in clinical trials.MethodsPooled data were analyzed from patients with T2DM treated…
read more here.
Keywords:
100 patient;
empagliflozin patients;
safety tolerability;
empagliflozin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Thrombosis research"
DOI: 10.1016/j.thromres.2019.04.008
Abstract: BACKGROUND Cerebral venous thrombosis (CVT), although rare, is potentially fatal. Few studies have investigated risk factors associated with recurrent venous thromboembolism (VTE) after a first CVT event of which most are from Caucasian populations. The…
read more here.
Keywords:
risk;
100 patient;
associated recurrent;
first cvt ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehac587
Abstract: AIMS To determine the risk of subsequent adverse clinical outcomes in anticoagulated patients with atrial fibrillation (AF) who experienced a new bleeding event. METHODS AND RESULTS Anticoagulated AF patients were followed in two prospective cohort…
read more here.
Keywords:
major bleeding;
per 100;
patient years;
100 patient ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.621
Abstract: Abstract Background Measuring antimicrobial usage is a hallmark of antimicrobial stewardship programs. Service –level antimicrobial consumption data is easily obtained but offers limited value to individual clinicians. More specific data via spot audit is resource…
read more here.
Keywords:
100 patient;
tool;
feedback;
spectrum ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of Clinical Microbiology and Antimicrobials"
DOI: 10.1186/s12941-020-00400-z
Abstract: Background Cefiderocol, ceftazidime-avibactam, ceftolozane-tazobactam, intravenous fosfomycin and plazomicin represent potential carbapenem sparing agents for extended-spectrum-beta-lactamase or AmpC beta-lactamase producing Escherichia coli infection. However, available data is limited in predicting the volume of carbapenem therapy which…
read more here.
Keywords:
100 patient;
carbapenem sparing;
infection;
patient days ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "British journal of nursing"
DOI: 10.12968/bjon.2017.26.sup20.s54
Abstract: BACKGROUND alternating pressure air mattresses (APAMs) support the prevention and management of pressure ulcers. A health and care NHS trust was seeking an APAM that would improve clinical outcomes in relation to pressure ulcers while…
read more here.
Keywords:
home;
100 patient;
patient clinical;
pressure ulceration ... See more keywords